ICYMI! Weekly Stock Market Recap. May 7-11, 2018


11-May-2018 16:09 PM



   In case you missed it! The U.S. stock market weekly recap with the most notable movers and economic recap day by day. 

   Monday U.S. Market continues the two days rallies with Dow Jones up +94.74 points, SPY +0.34%, IWM +0.84%, QQQ +0.83% and IBB +0.83%.

  Tuesday POTUS announces he will withdraw the U.S. from Iran nuclear deal and restore sanctions. Dow Jones close +2.92 points, SPY -0.01%, IWM +0.50%, QQQ, -0.10%, IBB -0.57%.

  Wednesday market gap up at open after the U.S. pull out of nuclear Iran deal. Dow Jones closed +183.63 points, IWM +0.56%, QQQ +1.09%, and IBB +1.35%.

   Thursday initial jobless claims 211k vs 219k, core CPI Index (MoM) 0.1% vs 0.2%. Dow Jones continues the three-day rallies closed up +196.54 points, SPY +0.93%, QQQ +1.04%, IBB -0.06%, IWM +0.53%.

   Friday President Trump unveils the plan to lower prescription drug prices. POTUS said to reduce regulation so can approve drugs faster, The plan for "American patients first".  Dow Jones ended the week with 5th straight day gain, up +90.92 points, SPY +0.23%, QQQ -0.09%, IWM +0.18%, The biotech sector with best day performance not seen since early April. IBB +2.75% and XBI +2.96%. 


  • Athenalhealth Inc (ATHN)-Paull Singer Elliott's make an all-cash offer of $155-$160 a share.
  • Tesla Inc (TSLA) CEO Musk bought 33,000 shares at $298.50
  • NVIDIA Corporation (NVDA) Stock up +4.02% to $148.68 ahead of the corporate earnings report, May 10.


  • Valeant Pharmaceuticals International, Inc (VRX) earnings report Q1 adjusted net income $312m vs $273M a year ago.
  • Impinji Inc (PI) stock gapped up with upgraded to Buy at Canaccord.
  • Akcea Therapeutics Inc (AKCA) and Ionis Pharmaceuticals Inc (IONS)- FDA document highlights volanesorsen 'safety concerns'



  • Eli Illy and Co (LLY) buy ARMO Biosciences Inc (ARMO) for $50.00 per share, or about $1.6B
  • Roku Inc (ROKU) earnings report
  • Booking Holdings Inc (BKNG) earnings report


Thanks for reading our blogs. Sign up for comments and share your ideas in our community. 

Contact us:

Twitter: @BiotechMoney18




Add Your Comment

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.